Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Rescape is a company pioneering the use of Virtual Reality (VR) in healthcare and frontline services. Its DR.VR platform, launched in 2019, helped reduce pain and anxiety amongst patients in hospitals and care homes. The company delivers VR content to patients through the Samsung Gear VR headset, a hard-plastic headset, that can be wiped down and disinfected along with VR sanitary eye masks that reduce chances of infection and irritation to patients. Through the company's technology, patients can experience ocean life, amusements parks and relax in some of the most beautiful settings in the world, all from the safety of the healthcare institution. The AR/VR in Healthcare Market is predicted to reach USD 30-40 billion by 2026, and Rescape aims to be a disruptor in this segment. The company will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£488,450
Created in 2015, Fourex provides an advanced and innovative self-service kiosk for exchanging over 150 currencies in both coins and notes. The company has grown its revenue by 175 % and it is continuing to grow. It will be live in 80 locations by the end of 2019. Fourex has a presence at Heathrow, Gatwick, and Stansted with access to 153 million passengers per year. It is located in 21 London underground stations with a combined 1.9 million passengers each day. In early 2018, Fourex has extended its business from 12 locations to 66 locations. It has won innovation awards from Lloyds Bank, Virgin, and Amazon. The company's revenue has increased by 175% in 2 years. Fourex's current partners are TfL/London, Westfield, Underground, Welcome Break, Intu, Moto and Roadchef. The company aims to become a principal multi-currency exchange solution. With the proceeds, the company will be accelerating its growth in the UK, by expanding the network of machines nationwide both in international travel hubs, high footfall retails and transit locations.
days to go:
Expired
investment:
£928,830
Swing has pioneered an IoT-connected micro-gym, the Swing Box, equipped with integrated free weights suitable for outdoor use. This innovative gym solution includes adjustable backrests and various dumbbells and kettlebells, catering to users of all fitness levels. Users can conveniently locate, reserve, and unlock the Swing Box using any smartphone, aiming to combat physical inactivity, which contributes to a significant number of deaths and costs the UK £7.4 billion annually. Swing's solution addresses the barriers of affordability, accessibility, and time in exercise by providing on-demand, free-access outdoor micro-gyms in communal parks and green spaces. With over 90% of UK residents within a 10-minute walk of public parks and only 32% meeting NHS guidelines for muscle-strength activity, Swing aims to lease these boxes to grant public access with leaseholders paying an annual fee of £2500 per box, covering maintenance and operations.
days to go:
Expired
investment:
£287,590
WiseAlpha is an investment platform that allow its members the opportunity to invest in secured loan investments from some leading UK companies.
days to go:
Expired
investment:
£579,150
Monva is an FCA approved, customer-centric intelligent comparison platform for financial products and services. It combines Artificial Intelligence (AI), machine learning and smart technology to enable its customers to select the most accurate financial product they wish to buy or invest in. Monva is initially targeting the Credit Card market, which will be followed by Loans, Energy, and Communications, which already represents a potential £3 billion opportunity. The company is targeting 80% of the adults in the UK market that have either never switched a financial product or switched only once. With the investment, the company will build the platform to make it more user friendly, develop strategic partnerships, and recruit staff who specialise technology and marketing.
days to go:
Expired
investment:
£479,440
Intelligent Health aim to get the whole community active by providing games and incentives such as ''beat the street''. By providing schools and communities with friendly competition to walk and cycle more by tapping their cards on ''beat boxes'', and with prizes and league tables on offer, Intelligent health are bringing communities together.
days to go:
Expired
investment:
£700,000
